InsideWorld        InsideDirect        InsideWeather        InsideTravel

CLICK HERE FOR YOUR FREE SUBSCRIPTION

InsideWorld
InsideDirect
InsideTravel
InsideWeather

Top Stories


Click here
if you want more information about advertising on this site.
Sign up
for News
Manage your
Account
Forgot your
Password
News
Services




 
more» 
  • Cyclist Rogers cleared to race after doping case

  • AIGLE, Switzerland (AP) — Former world time trial champion Michael Rogers can race again after cycling's governing body accepted that meat he ate in China likely caused his positive doping test.
  • London shares boosted by huge pharma sector manoeuvres

  • A bus passes the London Stock Exchange, in central London on September 22, 2011London shares closed higher on Tuesday as pharmaceuticals stocks soared amid restructuring in the sector, dealers said. The benchmark FTSE 100 index climbed 56.51 points or 0.85 percent to end the day at 6,681.76 points. "The pharma sector stood out (Tuesday)... on the back of news that two of the biggest players in the sector are making major changes to their business models," said Farhan Ahmad, a trader at TradeNext. Swiss pharmaceutical giant Novartis and British group GlaxoSmithKline (GSK) announced a major shake-up of their healthcare divisions on Tuesday in deals worth billions of dollars.



  • Novartis reshapes business with GSK, Lilly deals

  • FILE - The Oct. 19, 2012 file photo shows a Novartis employee in a laboratory of Novartis in Prangins near Nyon, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally. (AP Photo/Keystone, Yannick Bailly)GENEVA (AP) — Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more restructuring in the fast-changing industry.



  • Novartis reshapes business with GSK, Lilly dealshe

  • FILE - The Oct. 19, 2012 file photo shows a Novartis employee in a laboratory of Novartis in Prangins near Nyon, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally. (AP Photo/Keystone, Yannick Bailly)GENEVA (AP) — Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more restructuring in the fast-changing industry.



more» 
 

For more information about current affairs, business, economy, politics and more, use InsideWorld's free daily e-mail news service.

If you would like to receive news, but do not have an InsideWorld account yet, click below to setup your free account now and start receiving news right away.

 

 
Click here for your free subscription

Login to your account for
for advanced settings:

Email:
Password:


InsideWorld
is a collection of country and region web sites providing local news and information to a worldwide audience. Use InsideWorld’s headlines available on this site to access the latest stories. Or sign up today.

Advertising Privacy Statement FAQ Contact
RSS Feed